| Thu, Jan 29, 2009 |
|
Notes on Avanex-Bookham Merger
Bookham (BKHM) announced its fiscal Q4 results recently. Although there was nothing encouraging in the release per se, the bigger news was the prospective combination of it and Avanex (AVNX). Note that Avanex attempted a merger with Oplink (OPLK, Hold) back in 2002, which didn't go through because the Boards of the companies couldn't come to terms. This time around, the Boards of Directors of both BKHM and AVNX have agreed to a merger. Question is: Is it going to be synergistically incremental to the merged entity in terms of [More...]
-
home: iStockAnalyst....
|
| Thu, Nov 06, 2008 |
|
Earnings Review: 6th November 2008
Late on Thursday, media and entertainment company, Walt Disney Co. (NYSE: DIS) announced that its fourth fiscal quarter profit fell 13% to $760 million, or 40 cents a share [More...]
-
home: iStockAnalyst....
|
| Thu, Sep 11, 2008 |
|
Analyst Comments: Dell, The Andersons, Sunoco Logistics, Hershey, United Parcel Service, CME Group, Owens-Illinois, Avanex
Dell, Inc. (DELL) posted better-than-expected revenue for the second quarter of fiscal 2009 as aggressive pricing that helped drive unit sales. On a positive note, it does appear that price cuts were successful in taking some share, and operating expense reductions are ahead of expectations. On August 28, Dell released results for the second quarter of fiscal year 2009, ended August 1, 2008. Revenue for the quarter was $16,434 million in the quarter, ahead of our $15,958 million estimate and 11.2% above the $14,776 million reported in the second quarter of fiscal 2008. However, we are concerned that Dell is returning to a period of strong share gains over profits. We therefore maintain a Hold rating on DELL shares and cut our six-month price target to $20.50. At the beginning of fiscal year 2008, Dell announced five [More...]
-
home: iStockAnalyst....
|
| Tue, Jul 01, 2008 |
|
Analyst Comments: Immucor, UST Inc, Avanex, American Capital, deCODE, H&R Block, Equinix
A number of positive trends and developments make us optimistic about blood-testing products maker Immucor, Inc.'s (BLUD) growth. Gross margins are expected to regain momentum from the eventual growth in reagent sales, manufacturing efficiencies, and price increases. The additional worldwide placements of Galileo (a walk-away instrument...
[More...]
-
home: iStockAnalyst....
|
| Fri, May 02, 2008 |
|
NASDAQ Technical Picture - Expansion
-
home: iStockAnalyst....
|
|
More Blogs
|